These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38148258)

  • 21. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.
    Akeel N; Lan N; Stocchi L; Costedio MM; Dietz DW; Gorgun E; Kalady MF; Karagkounis G; Kessler H; Remzi FH
    J Gastrointest Surg; 2017 Jan; 21(1):49-55. PubMed ID: 27796635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
    Sauer J; Sobolewski K; Dommisch K
    Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of Tumor Response Between Flexible Sigmoidoscopy and Magnetic Resonance Imaging in Patients Undergoing Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Retrospective Review.
    Rojas MA; Cataneo J; Gagnon-Konamna M; Borsuk DJ; Jarzabek AJ; Marecik SJ; Park JJ; Kochar K
    Am Surg; 2023 Jun; 89(6):2595-2599. PubMed ID: 35617529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.
    Bilimoria KY; Bentrem DJ; Stewart AK; Winchester DP; Ko CY
    J Clin Oncol; 2009 Sep; 27(25):4177-81. PubMed ID: 19636004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience.
    Gilshtein H; Ghuman A; Dawoud M; Yellinek S; Kent I; Sharp SP; Nagarajan A; Wexner SD
    Am Surg; 2021 May; 87(5):708-713. PubMed ID: 33169626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is local excision an appropriate treatment modality in patients presenting with early-stage (cT1 N0 M0) rectal adenocarcinoma?
    Roat-Shumway S; Tonelli C; Singer M; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
    Surgery; 2023 Mar; 173(3):665-673. PubMed ID: 36273975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
    Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project.
    Pellino G; Alós R; Biondo S; Codina-Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; Cervantes A; García-Granero E;
    Eur J Surg Oncol; 2021 Feb; 47(2):276-284. PubMed ID: 32950316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
    Charlton ME; Hrabe JE; Wright KB; Schlichting JA; McDowell BD; Halfdanarson TR; Lin C; Stitzenberg KB; Cromwell JW
    J Gastrointest Surg; 2016 May; 20(5):1002-11. PubMed ID: 26658793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between cancer center accreditation and performance on publicly reported quality measures.
    Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY
    Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer.
    Brady JT; Xu Z; Scarberry KB; Saad A; Fleming FJ; Remzi FH; Wexner SD; Winchester DP; Monson JRT; Lee L; Dietz DW;
    J Am Coll Surg; 2018 May; 226(5):881-890. PubMed ID: 29580675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal cancer and teaching hospitals: hospital teaching status affects use of neoadjuvant radiation and survival for rectal cancer patients.
    Stewart DB; Hollenbeak C; Desharnais S; Camacho F; Gladowski P; Goff VL; Wang L
    Ann Surg Oncol; 2013 Apr; 20(4):1156-63. PubMed ID: 23184292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
    de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
    Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
    Miller ME; Bleicher RJ; Kaufman CS; Kurtzman SH; Chang C; Wang CH; Pollitt KA; Connolly J; Winchester DP; Yao KA
    Ann Surg Oncol; 2019 May; 26(5):1202-1211. PubMed ID: 30684159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.